Enterin to Announce Top-Line Results From the Phase 2b Study for Parkinson’s Disease
Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, today announced that it will host a webinar to present top-line results from the Phase 2b (KARMET) study in patients with Parkinson’s disease on Thursday, Jan. 27 at 2:30 pm EST, mehr …
www.guetsel.de/content/35483/enterin-to-announce-top-line-results-from-the-phase-2b-study-for-parkinsons-disease.html
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending an extension of the Novo Seven (eptacog alfa) label to include treatment of women suffering from severe haemorrhage after giving birth, when medications used to induce uterine contractions and reduce bleeding (uterotonics) are insufficient to stop the bleeding, mehr …
www.guetsel.de/content/41695/heavy-bleeding-after-giving-birth-is-globally-a-leading-cause-of-death-in-new-mothers.html
Once-weekly insulin icodec demonstrates superior reduction in HbA1c
Mehr …
p style="line-height:150%;">www.guetsel.de/content/51554/once-weekly-insulin-icodec-demonstrates-superior-reduction-in-hba1c.html
Siemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges
Clinical labs face critical operational challenges that impede productivity—more patient samples to test, staffing shortages, and more documentation requirements. , mehr …
www.guetsel.de/content/71097/siemens-healthineers-launches-atellica-ci-analyzer-compact-testing-system-to-tackle-lab-challenges.html
Erfolgsstory in der Lifescience Industrie: 30 Jahre »X act Cologne Clinical Research«
Die »X act Cologne Clinical Research« GmbH ist eine spezialisierte Auftragsforschungsorganisation (CRO), die sich ausschließlich auf klinisches Datenmanagement und Biostatistik fokussiert, mehr …
www.guetsel.de/content/101676/erfolgsstory-in-der-lifescience-industrie-30-jahre-x-act-cologne-clinical-research.html
Karolinska University Hospital signs Memorandum of Understanding with Major Academic Medical Center in the United States
Karolinska University Hospital has signed a Memorandum of Understanding (MOU) with Brigham and Women’s Hospital, which is located in Boston, Massachusetts to Explore Potential for Scientific, Educational, and Cultural Collaboration, mehr …
www.guetsel.de/content/40381/karolinska-university-hospital-signs-memorandum-of-understanding-with-major-academic-medical-center-in-the-united-states.html
GB Sciences Signs Licensing Deal With «EndoPure« Life Sciences for 5 Percent Gross Sales Royalty & Sponsorship of First in Human Trial for Their Cannabinoid Based Parkinson’s Drug
As a part of their Exclusive Licensing Deal, “EndoPure” Life Sciences will finance and sponsor first in human clinical trials, which help to advance GB Sciences’ cannabinoid based products globally, mehr …
www.guetsel.de/content/94248/gb-sciences-signs-licensing-deal-with-endopure-life-sciences-for-5-percent-gross-sales-royalty-und-sponsorship-of-first-in-human-trial-for-their-cannabinoid-based-parkinsons-drug.html
Novo Nordisk achieves primary objectives of Onwards 1 and 6 trials
Novo Nordisk today announced headline results from the main phases of Onwards 1 (52 weeks) and Onwards 6 (26 weeks) phase 3a trials with once-weekly insulin icodec, mehr …
www.guetsel.de/content/44467/novo-nordisk-achieves-primary-objectives-of-onwards-1-and-6-trials.html
Attgeno reports on the completed Phase I study of the drug candidate, Supernitro
The last of 38 study participants were treated with Supernitro on 18 May, and the substance has shown good safety and tolerability, mehr …
www.guetsel.de/content/45178/attgeno-reports-on-the-completed-phase-i-study-of-the-drug-candidate-supernitro.html
New clinical study realized with a Belgian supplement shows promising results against Covid 19
A daily intake of a new dietary supplement (Nasafytol) containing an oral combination of Quercetin (65 milligrams), Curcumin (42 milligrams) and Vitamin D 3 (2.2 micrograms) for 14 days by early-stage mild to moderately symptomatic Covid 19 outpatients, resulted in more rapid clearance of the SARS-CoV-2 viral infection, more rapid resolution of Covid 19 associated acute symptoms and more rapid improvement in the inflammatory marker CRP levels; leading to speedier recovery of the patients, mehr …
www.guetsel.de/content/51668/new-clinical-study-realized-with-a-belgian-supplement-shows-promising-results-against-covid-19.html
Heartseed and Novo Nordisk announce first patient dosed in clinical study with HS-001—a cell therapy designed to restore heart function in people with advanced heart failure
HS 001 consists of clusters of purified heart muscle cells derived from induced pluripotent stem cells (iPSCs), mehr …
www.guetsel.de/content/58964/heartseed-and-novo-nordisk-announce-first-patient-dosed-in-clinical-study-with-hs-001-a-cell-therapy-designed-to-restore-heart-function-in-people-with-advanced-heart-failure.html
Pharming: Joenja (Leniolisib) von der FDA als erste und einzige Behandlung für APDS zugelassen
APDS (aktivierte Phosphoinositid 3 Kinase delta (PI3Kδ) Syndrom) ist eine seltene und fortschreitende primäre Immundefizienz, mehr …
www.guetsel.de/content/62532/pharming-joenja-leniolisib-von-der-fda-als-erste-und-einzige-behandlung-fuer-apds-zugelassen.html
Clinical Endpoint Adjudication: Ethical Enhances eAdjudication With an Innovative AI Powered Conversational Documents Search
By leveraging advanced natural language processing and machine learning capabilities, Ethical’s new AI-powered conversational documents search tool reduces the time and effort required to find critical information and enhances the overall efficiency and quality of the endpoint adjudication process, mehr …
www.guetsel.de/content/86308/clinical-endpoint-adjudication-ethical-enhances-eadjudication-with-an-innovative-ai-powered-conversational-documents-search.html
Blue Note Therapeutics Receives Breakthrough Device Designation for Prescription-Only Digital Therapeutic for Acute Myeloid Leukemia
Blue Note Therapeutics, a prescription digital therapeutics company dedicated to easing the burden of cancer and improving outcomes, today announced that the U. S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for BNT200, mehr …
www.guetsel.de/content/34124/blue-note-therapeutics-receives-breakthrough-device-designation-for-prescription-only-digital-therapeutic-for-myeloid-leukemia.html
Karolinska University Hospital First to Give Stem Cells to Foetus with Severe Osteoporosis
A new treatment is being trialled to help children born with a severe variant of osteoporosis, osteogenesis imperfecta, mehr …
www.guetsel.de/content/36030/karolinska-university-hospital-first-to-give-stem-cells-to-foetus-with-severe-osteoporosis.html
Hope for leukaemia patients through discovery at Karolinska University Hospital
In a recently published study, Nikolas Herold and Martin Jädersten from Karolinska University Hospital show how acute myeloid leukaemia can be treated more effectively. They have reused an already proven medicinal product, mehr …
www.guetsel.de/content/49090/hope-for-leukaemia-patients-through-discovery-at-karolinska-university-hospital.html
FDA lässt Lytgobi (Futibatinib) Tabletten von Taiho für zuvor therapierte, inoperable, lokal fortgeschrittene oder metastasierte intrahepatische Cholangiokarzinome zu
Lytgobi (englische Aussprache »Light Goh Bee«) erzielte in der primären Analyse der zulassungsrelevanten klinischen Studie eine objektive Ansprechrate von 42 Prozent und eine mediane Dauer des Ansprechens von 9,7 Monaten, mehr …
www.guetsel.de/content/51561/fda-laesst-lytgobi-futibatinib-tabletten-von-taiho-fuer-zuvor-therapierte-inoperable-lokal-fortgeschrittene-oder-metastasierte-intrahepatische-cholangiokarzinome-zu.html
Insight Treatment Provides Help for Teen Mental Health in the Valley
Insight Treatment has provided counseling for teenagers in the valley for more than 30 years. To help more teenagers, this month they are announcing an expansion of their focus on mental health. , mehr …
www.guetsel.de/content/52947/insight-treatment-provides-help-for-teen-mental-health-in-the-valley.html
Novo Nordisk invests DKK 5.4 bn Danish kroner in expansion of clinical manufacturing facilities in Bagsværd, Denmark
Novo Nordisk today announced plans to invest 5.4 bn Danish kroner in the expansion of existing facilities in Bagsværd. The plans also include the construction of a new plant located in extension of the existing facilities, mehr …
www.guetsel.de/content/54158/novo-nordisk-invests-dkk-5-4-bn-danish-kroner-in-expansion-of-clinical-manufacturing-facilities-in-bagsv-aelig-rd-denmark.html
Success Point College UAE Announces Its New International Academic Partnership With Notre Dame De Namur University in the United States
Success Point College (SPC) extends its international academic collaboration to the United States. SPC announced today its new academic partnership with Notre Dame De Namur University (NDNU), the third oldest college in California and the first college in the state to grant women a Bachelor’s degree, mehr …
www.guetsel.de/content/56201/success-point-college-uae-announces-its-new-international-academic-partnership-with-notre-dame-de-namur-university-in-the-united-states.html
Gewebe Injektion lindert Rückenschmerzen, 60 Prozent der Patienten berichten in Studie von Clinical Radiology of Oklahoma von Fortschritten
Eine minimal invasive Behandlung, bei der fremdes Bandscheibengewebe in die Wirbelsäule injiziert wird, um die mit einer degenerativen Erkrankung einhergehenden Schmerzen zu lindern, bringt längerfristig signifikante Verbesserungen bei Schmerz und Funktion, mehr …
www.guetsel.de/content/60478/gewebe-injektion-lindert-rueckenschmerzen-60-prozent-der-patienten-berichten-in-studie-von-clinical-radiology-of-oklahoma-von-fortschritten.html
Pädiatrie Konferenzen 2023, 25. bis 27. September 2023, Prag, Longdom
Die Pädiatrie Konferenz 2023 richtet sich an auf Kindermedizin spezialisierte Gesundheitsfachkräfte, die zusammenkommen, um die neuesten Forschungsergebnisse zu diskutieren, Fallstudien vorzustellen und bewährte klinische Praktiken auszutauschen, mehr …
www.guetsel.de/content/67421/paediatrie-konferenzen-2023-25-bis-27-september-2023-prag-longdom.html
Aronora Secures Investment From New York Blood Center
Aronora is Revolutionizing Blood Clot Treatment with Groundbreaking Innovations, mehr …
www.guetsel.de/content/76749/aronora-secures-investment-from-new-york-blood-center.html
Wenn der Körper nicht mehr kann – wie die Stoffwechseltherapie neue Energie bringt
Chronische Erschöpfung trotz gesunder Ernährung und Bewegung? Viele Menschen erleben genau das. Doch es gibt eine Lösung: Die gezielte Stoffwechseltherapie per Infusion kann die Zellenergie innerhalb weniger Tage spürbar steigern. Das Besondere: Die Wirkung lässt sich durch Laborwerte und bildgebende Verfahren wie die Echokardiographie objektiv messen, mehr …
www.guetsel.de/content/102084/wenn-der-koerper-nicht-mehr-kann-wie-die-stoffwechseltherapie-neue-energie-bringt.html
Wolters Kluwer führt KI-gestützte »UpToDate« Enterprise Edition in Europa ein
Revolutionierung der klinischen Entscheidungsunterstützung für Leistungserbringer mit KI für Suche, Nutzungsanalyse und mehr, mehr …
www.guetsel.de/content/105396/wolters-kluwer-fuehrt-ki-gestuetzte-uptodate-enterprise-edition-in-europa-ein.html
Beautylicious, Zero Martinez Alvarez
Münsterstraße 29, 33330 Gütersloh, mehr …
https://www.guetsel.de/webcard/beautylicious-zero-martinez-alvarez/8758.html
